1h Free Analyst Time
The CBD Ingredients Market grew from USD 6.52 billion in 2023 to USD 7.38 billion in 2024. It is expected to continue growing at a CAGR of 14.05%, reaching USD 16.38 billion by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
The market spans various sectors, including pharmaceuticals, cosmetics, food and beverages, and pet care, owing to its broad application range. The scope extends from cultivation and extraction to distributing CBD-infused products to end consumers, highlighting an intricate value chain. CBD ingredients find applications across various sectors, including pharmaceuticals, nutraceuticals, cosmetics, and food and beverages. In pharmaceuticals, CBD is used for its therapeutic properties in treating conditions such as anxiety, epilepsy, and chronic pain. In the nutraceutical sector, it is incorporated into supplements for wellness benefits. Cosmetics infused with CBD are known for their anti-inflammatory and antioxidant properties, while the food and beverage industry utilizes CBD to create wellness-oriented edible products. Several factors propel the growth of the CBD ingredients market, including the growing prevalence of chronic diseases globally, increased investment in R&D of CBD ingredients, and increasing consumer focus on wellness and natural remedies. However, the cannabidiol market is facing certain challenges, such as stringent quality and safety standards required for CBD products, consumer misconceptions, and the stigma associated with cannabis products. On the other hand, the ongoing development of novel CBD formulations and delivery methods and strategic partnerships with food, beverage, cosmetics, and pharmaceutical companies present potential growth opportunities for the CBD ingredients market.
Regional Insights
The North American region, notably the United States and Canada, continues to be a major market for CBD ingredients due to increasing legalization, societal acceptance, and an expanding array of CBD-infused products. Regulatory advancements, especially in the U.S. following the 2018 Farm Bill, have supported the expansion of CBD in both consumer and pharmaceutical domains. In South America, the burgeoning interest in CBD ingredients is noteworthy, particularly in Uruguay and Colombia, which have taken progressive steps toward cannabis legalization. This region shows growth potential bolstered by agricultural capabilities and regulatory shifts. Europe's CBD market exhibits considerable diversity in regulation and countries such as Germany, the UK, and Switzerland are at the forefront, driven by favorable regulatory atmospheres and high consumer interest. However, the EU's Novel Food Regulation has been a critical regulatory milestone, providing a pathway for CBD foods and supplements. The Middle East presents a challenging market for CBD products, with stringent anti-cannabis laws across many countries. However, there is a small but growing interest in CBD for medicinal purposes. Africa's CBD market is in early development, with South Africa being the most notable market. The continent shows potential for both the cultivation of hemp and the development of CBD markets, driven by a growing awareness of CBD's health and wellness benefits. The APAC region is witnessing a slow but steady interest in CBD, primarily led by countries such as Australia and Thailand. China is appearing as a significant player in the CBD hemp cultivation and export markets despite stringent regulations around CBD consumption. Recent patents in China focus on hemp genetics and CBD extraction technologies. Japan maintains a strict zero-tolerance policy for THC, placing an emphasis on CBD purity. Recent regulatory relaxations have led to an increase in available CBD-infused products, from skincare to supplements. India's CBD market is in its nascent stages, with significant legal and cultural barriers to widespread adoption. However, the traditional use of cannabis in Ayurvedic practices and growing awareness signal a future market potential.Market Insights
Market Dynamics
- The market dynamics represent an ever-changing landscape of the CBD Ingredients Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
- Growing prevalence of chronic diseases globally
- Increased investment in R&D of CBD ingredients
- Rising consumer focus on wellness and natural remedies
Market Restraints
- Stringent quality and safety standards required for CBD products
Market Opportunities
- Ongoing development of novel CBD formulations and delivery methods
- Strategic partnerships with food, beverage, cosmetics, and pharmaceutical companies
Market Challenges
- Consumer misconceptions and the stigma associated with cannabis products
Market Segmentation Analysis
- Type: Increasing preference for full spectrum CBD due to its therapeutic benefits
- Application: Expanding application of CBD ingredients in nutraceuticals & dietary supplements to support overall health
Industry Insights
- Market Disruption Analysis
- Porter’s Five Forces Analysis
- Value Chain & Critical Path Analysis
- Pricing Analysis
- Technology Analysis
- Patent Analysis
- Trade Analysis
- Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the CBD Ingredients Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the CBD Ingredients Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Recent Developments
Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch
Aurora Cannabis Inc. launched three distinct cannabis-infused beverages tailored exclusively for its veteran patient community. Demonstrating a steadfast commitment to fulfilling patient needs with alternative cannabis forms, Aurora introduces products designed for taste, potency, and diversity. The lineup, produced alongside Vacay and Versus, features Neon Rush, Strawberry Pineapple Tropical Fizz, and Pineapple Coconut Fizz, each available in 355ml cans utilizing SōRSE emulsion technology to minimize cannabis aroma and taste. These beverages, offering a harmonious blend of THC and CBD in varying ratios, cater to the preferences and well-being of their patients.Cornbread Hemp Announces Acquisition of Manufacturing Partner, Launching New Pricing To Disrupt CBD Industry
Cornbread Hemp has significantly transformed the CBD industry by achieving full vertical integration through the acquisition of its manufacturing partner. This strategic move enables Cornbread Hemp to reduce its product prices and ensure the highest quality in its comprehensive range of full-spectrum CBD offerings. With a deeply ingrained commitment to excellence, Cornbread Hemp utilizes a unique strain of low-THC cannabis, meticulously hand-shucked for its Flower-Only extraction process, culminating in the creation of USDA organic certified products. This integration enhances quality control, enables seamless seed-to-sale tracking for unparalleled transparency, and safeguards proprietary hemp genetics, ensuring consistent product excellence.CBDTokyo launches a new highly concentrated CBD isolate oil, CBD Oil 18.2% (IPPATSU)
HealthyTOKYO has launched its most concentrated CBD oil yet, CBD Oil 18.2% (IPPATSU), boasting an unparalleled 1820mg of high-quality CBD isolate in a 10ml bottle. This premium product, crafted to cater to the demanding lifestyles of urban dwellers, marks a significant advancement in the brand's offerings, nearly doubling the CBD content of its previously most popular product, CBD Oil 10.4% (TEN-SHI). The new oil ensures an easy intake with just two drops needed to reach the recommended serving, designed to support quality rest and sleep.Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the CBD Ingredients Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.Key Company Profiles
The report delves into recent significant developments in the CBD Ingredients Market, highlighting leading vendors and their innovative profiles. These include Aurora Cannabis Inc., Bedrocan, BIOTA Biosciences LLC, CannazALL, Cannoid LLC, Canopy Growth Corp., CBD American Shaman LLC, CV Sciences, Inc., Elixinol, Endoca BV, Folium Biosciences, Gaia Botanics, Global Cannabinoids, Green Roads Inc., Happie Hemp Pvt. Ltd., Isodiol International Inc,, Kazmira LLC, Maricann, Inc., Medical Marijuana Inc., Mile High Labs International Inc., NuLeaf Naturals, LLC, PharmaHemp d.o.o., Rhizo Sciences, Sequoya, and SPARKCBD.Market Segmentation & Coverage
This research report categorizes the CBD Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:Source
- Hemp-Derived CBD
- Marijuana-Derived CBD
Type
- Broad Spectrums
- Full Spectrums
- Isolate Spectrums
Application
- Food & Beverage
- Nutraceuticals & Dietary Supplements
- Personal Care & Cosmetics
- Pharmaceutical
Region
Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website
Table of Contents
1. Preface
2. Research Methodology
5. Market Insights
6. CBD Ingredients Market, by Source
7. CBD Ingredients Market, by Type
8. CBD Ingredients Market, by Application
9. Americas CBD Ingredients Market
10. Asia-Pacific CBD Ingredients Market
11. Europe, Middle East & Africa CBD Ingredients Market
12. Competitive Landscape
13. Competitive Portfolio
List of Figures
List of Tables
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aurora Cannabis Inc.
- Bedrocan
- BIOTA Biosciences LLC
- CannazALL
- Cannoid LLC
- Canopy Growth Corp.
- CBD American Shaman LLC
- CV Sciences, Inc.
- Elixinol
- Endoca BV
- Folium Biosciences
- Gaia Botanics
- Global Cannabinoids
- Green Roads Inc.
- Happie Hemp Pvt. Ltd.
- Isodiol International Inc,
- Kazmira LLC
- Maricann, Inc.
- Medical Marijuana Inc.
- Mile High Labs International Inc.
- NuLeaf Naturals, LLC
- PharmaHemp d.o.o.
- Rhizo Sciences
- Sequoya
- SPARKCBD
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 199 |
| Published | June 2024 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 7.38 Billion |
| Forecasted Market Value ( USD | $ 16.38 Billion |
| Compound Annual Growth Rate | 14.0% |
| Regions Covered | Global |
